Allovir, Inc. ALVR on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
1754068
1754068
EIN:
83-1971007
83-1971007
(CF Office: 03 Life Sciences)
Business address:
1100 WINTER STREET, WALTHAM, MA, 02451
Phone: (617) 433-2605
1100 WINTER STREET, WALTHAM, MA, 02451
Phone: (617) 433-2605
Mailing address:
1100 WINTER STREET, WALTHAM, MA, 02451
1100 WINTER STREET, WALTHAM, MA, 02451
Category:
Emerging growth company
Emerging growth company
Former names:
- ViraCyte, Inc. - filings through 2018-10-02
Filings:
572 EDGAR filings since October 2, 2018
572 EDGAR filings since October 2, 2018
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- January 24, 2025 - 144: Report of proposed sale of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 24, 2025 - 144: Report of proposed sale of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 24, 2025 - 144: Report of proposed sale of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 17, 2025 - S-4/A: Registration of securities, business combinations - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 15, 2025 - 425: Prospectuses and communications, business combinationsOpen documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- January 15, 2025 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 3.03 - Material Modification to Rights of Security Holders
- 5.03 - Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- 9.01 - Financial Statements and Exhibits
- January 10, 2025 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- January 10, 2025 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 5.07 - Submission of Matters to a Vote of Security Holders
- December 20, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
- November 8, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- November 12, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 9, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 13, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- March 15, 2024 - 10-K: Annual report for year ending December 31, 2023Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- December 6, 2024 - DEF 14A: Other definitive proxy statementsOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 26, 2024 - PRE 14A: Other preliminary proxy statementsOpen documentClick to Open document FilingOpen filingClick to Open filing
- April 23, 2024 - DEF 14A: Other definitive proxy statementsOpen documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- January 13, 2025 - 4: Statement of changes in beneficial ownership of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 13, 2025 - 4: Statement of changes in beneficial ownership of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- January 13, 2025 - 4: Statement of changes in beneficial ownership of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- October 11, 2024 - SC 13G: Statement of Beneficial Ownership by Certain InvestorsOpen documentClick to Open document FilingOpen filingClick to Open filing
- August 2, 2024 - SC 13G/A: Statement of Beneficial Ownership by Certain Investors - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2024 - SC 13G/A: Statement of Beneficial Ownership by Certain Investors - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
Form type | Form description | Filing date | Reporting date |
---|
0
Showing 1 to 48 of 572 entries
Data source:
CIK0001754068.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors